Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jun 25, 2001
Tools & Techniques

Kinase inhibitor pipeline

BioCentury | Apr 9, 2001
Clinical News

Glivec: Phase I data; NDA under review

BioCentury | Apr 9, 2001
Clinical News

Glivec: Pilot data; NDA filed in CML

BioCentury | Dec 11, 2000
Clinical News

Glivec: Phase II

Items per page:
1 - 5 of 5